With increasing rates of depression worldwide, clinicians are rethinking traditional treatment frameworks by integrating major depressive disorder and treatment innovations into routine psychiatric care. New approaches such as esketamine nasal spray, deep brain stimulation, and digital therapeutics are reshaping how depression is addressed, particularly in treatment-resistant populations. Psychotherapies like cognitive control training and acceptance-based strategies are also showing promising results. Combining neurobiological insights with technology, clinicians can now predict treatment response with greater accuracy, minimizing trial-and-error prescribing. This precision model supports faster recovery and fewer relapses. Emphasizing patient-centered care, new innovations allow for better symptom tracking, greater adherence, and reduced long-term impact on daily functioning.
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Trauma: Till death do us part
John Michael Weber, Trauma Healed Life Coach, United States
Title : PIVOT: Predictive intervention for vaping using resonance modeling of oscillatory, psychological, and trigger dynamics
Aadya, Issaquah High School, United States
Title : Beyond the myths: Bipolar disorder, recovery, and the power of compassionate care
Pakesta Washington, Washington Elite Nursing Consultants, United States
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College, United States
Title : Dr Jekyll and Mr. Hyde revealed: Tales from the default mode network
Christopher Ashton, TEDDs on Chapel, Center for Recovery, Canada